 SAN CARLOS, Calif., Feb. 17, 2022 GLOBE NEWSWIRE -- Vaxcyte, Inc. Nasdaq: PCVX, a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that it will report financial results for the fourth quarter and full year 2021 after market close on February 28, 2022. Company management will host a conference call and webcast beginning at 4:30 p.m. ET 1:30 p.m. PT that day to discuss the financial results and provide a business update. 